Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Acute stroke treatment in the ambulance with a nitroglycerin patch
2016-005086-31Phase 3Terminated
- Sponsor
- University Medical Center Utrecht
- Start
- Jun 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of nitroglycerin in stroke, ischemic stroke and intracerebral hemorrhage (ICH) (2 arms), sponsored by University Medical Center Utrecht. Primary endpoint: Modified Rankin Scale score at 90 days. Started Jun 2017; status: terminated.
02
Drugs
nitroglycerin
03
Conditions
strokeischemic strokeintracerebral hemorrhage (ICH)
Beyond the preview
Go deeper on 2016-005086-31.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-005086-31.